ketorolac has been researched along with naloxone in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (10.53) | 18.2507 |
2000's | 6 (31.58) | 29.6817 |
2010's | 11 (57.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Castañeda-Hernández, G; Flores-Murrieta, FJ; Granados-Soto, V; Hong, E; López-Muñoz, FJ | 1 |
Miranda, HF; Pinardi, G; Sierralta, F | 1 |
Rattan, AK; Tejwani, GA | 1 |
Dunbar, SA; Karamian, I; Zhang, J | 1 |
Deveci, MS; Dogrul, A; Gul, H; Gülmez, SE; Ossipov, MH; Porreca, F; Tulunay, FC | 1 |
Tsagareli, MG; Tsiklauri, N; Viatchenko-Karpinski, V; Voitenko, N | 1 |
Abzianidze, E; Gurtskaia, G; Nozadze, I; Tsagareli, MG; Tsiklauri, N | 1 |
Gurtskaia, G; Nebieridze, M; Nozadze, I; Tsagareli, MG; Tsiklauri, N | 1 |
Benner, RW; Freeman, H; Isaacs, AN; Nisly, SA; O'Sullivan, JA; Schwinghammer, AJ | 1 |
Abzianidze, E; Gorgiladze, T; Nozadze, I; Tsagareli, M | 1 |
Abzianidze, E; Gurtskaia, G; Nebieridze, M; Nozadze, I; Pirkulashvili, N; Tsagareli, MG; Tsiklauri, N | 1 |
Kvachadze, I; Tsagareli, M; Tsagareli, N; Tsiklauri, N | 1 |
1 review(s) available for ketorolac and naloxone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
18 other study(ies) available for ketorolac and naloxone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Evidence against the participation of mu- and kappa-opioid receptors in the analgesic activity of ketorolac in rats.
Topics: Analgesics; Analgesics, Non-Narcotic; Animals; Ethylketocyclazocine; Female; Ketorolac; Morphine; Movement Disorders; Naloxone; Pain Measurement; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Time Factors; Tolmetin | 1995 |
Previous administration of indomethacin or naloxone did not influence ketorolac antinociception in mice.
Topics: Animals; Cecum; Cerebral Ventricles; Indomethacin; Injections, Intraperitoneal; Ketorolac; Mice; Naloxone; Time Factors; Tolmetin | 1993 |
Antagonism of antinociception produced by intrathecal clonidine by ketorolac in the rat: the role of the opioid system.
Topics: Adrenergic alpha-Agonists; Analgesia; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonidine; Dose-Response Relationship, Drug; Drug Interactions; Injections, Spinal; Ketorolac; Male; Naloxone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Spinal Cord | 2000 |
Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Hyperalgesia; Injections, Spinal; Ketorolac; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Pain Measurement; Pain, Intractable; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance Withdrawal Syndrome | 2007 |
The local antinociceptive actions of nonsteroidal antiinflammatory drugs in the mouse radiant heat tail-flick test.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Dipyrone; Disease Models, Animal; Dose-Response Relationship, Drug; Hot Temperature; Injections, Intradermal; Injections, Intraperitoneal; Ketorolac; Lysine; Male; Mice; Mice, Inbred BALB C; Motor Activity; Naloxone; Narcotic Antagonists; Pain; Reaction Time; Sodium Salicylate; Tail; Time Factors | 2007 |
Non-opioid tolerance in juvenile and adult rats.
Topics: Age Factors; Analgesics; Analgesics, Opioid; Animals; Behavior, Animal; Drug Tolerance; Ketorolac; Morphine; Naloxone; Piroxicam; Rats; Time Factors | 2010 |
Opioid sensitivity of nucleus raphe magnus ater analgesia by nonsteroidal anti-inflammatory drugs.
Topics: Analgesia; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dipyrone; Drug Interactions; Drug Tolerance; Ketorolac; Male; Microinjections; Morphine; Naloxone; Nociceptors; Pain; Periaqueductal Gray; Piroxicam; Raphe Nuclei; Rats; Spinal Cord | 2011 |
Antinociceptive tolerance to NSAIDs microinjected into dorsal hippocampus.
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Diclofenac; Drug Resistance; Hippocampus; Ketorolac; Male; Microinjections; Naloxone; Narcotic Antagonists; Pain; Piroxicam; Rats; Rats, Wistar | 2014 |
Continuous Infusion Ketorolac for Postoperative Analgesia Following Unilateral Total Knee Arthroplasty.
Topics: Aged; Analgesia; Analgesics, Opioid; Arthroplasty, Replacement, Knee; Female; Humans; Ketorolac; Male; Middle Aged; Naloxone; Pain Management; Pain Measurement; Pain, Postoperative; Retrospective Studies | 2017 |
NON-STEROIDAL ANTI-INFLAMMATORY DRUGS'S ANTINOCICEPTION MEDIATED BY THE OPIOID MECHANISM IN THE NUCLEUS RAPHE MAGNUS.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dipyrone; Ketorolac; Male; Microinjections; Naloxone; Narcotic Antagonists; Nociception; Nucleus Raphe Magnus; Opioid Peptides; Piroxicam; Rats; Reaction Time | 2017 |
Antinociceptive tolerance to NSAIDs in the anterior cingulate cortex is mediated via endogenous opioid mechanism.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Tolerance; Gyrus Cinguli; Ketorolac; Male; Microinjections; Naloxone; Narcotic Antagonists; Opioid Peptides; Pain; Piroxicam; Rats, Wistar | 2018 |
NALOXONE AND CTOP BLOCK NSAIDS-INDUCED ANTINOCICEPTION IN ANTERIOR CINGULATE CORTEX OF RATS.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Gyrus Cinguli; Ketorolac; Naloxone; Narcotic Antagonists; Pain Perception; Rats; Rats, Wistar; Somatostatin | 2019 |